project id: TCGA-SKCM; case submitter id: TCGA-DA-A1I5; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.81; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.4; rna integrity number: 7.6; age at index: 27; days to birth: -10017; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1976; age at diagnosis: 10017; ajcc pathologic m: M1c; ajcc pathologic n: N0; ajcc pathologic stage: Stage IV; ajcc pathologic t: T1a; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 4107.0; icd 10 code: C44.9; last known disease status: not reported; morphology: 8720/3; primary diagnosis: Malignant melanoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Skin, NOS; synchronous malignancy: No; tissue or organ of origin: Skin, NOS; tumor grade: Not Reported; year of diagnosis: 2003; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 2671; days to sample procurement: 0; initial weight: 110.0; portion submitter id: TCGA-DA-A1I5-06A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 90.0; percent tumor nuclei: 85.0;